Merrion Investment Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
SI
CPC
KAS
GGI
FWCM
QCM
Merrion Investment Management's NVS Position: Q2 2026 in Review
Merrion Investment Management held its Novartis (NVS) position steady in Q2 2026 at 2,080 shares worth $326K. The position accounts for 0.15% of the portfolio, ranked #95.
Merrion Investment Management first reported a position in NVS in Q4 2020 and has held it in 23 quarters since. The position peaked at $382K in Q4 2020. 734 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Merrion Investment Management held 2,080 shares of Novartis worth $326K as of Q2 2026.
- Merrion Investment Management left its Novartis share count unchanged in Q2 2026.
- Novartis made up 0.15% of Merrion Investment Management's portfolio in Q2 2026, its #95 holding.
- Merrion Investment Management first reported a position in Novartis in Q4 2020 and has held it in 23 quarters since.
- Merrion Investment Management's Novartis position peaked at $382K in Q4 2020.
- 734 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Merrion Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.